Azopt, Augentropfensuspension

7680552360017 CH-55236 Augentropfensuspension

Associated product:

AZOPT susp opht fl 5 ml
Azopt, Augentropfensuspension
Azopt, Augentropfensuspension
Azopt, Augentropfensuspension
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
ml
Galenic form
Augentropfensuspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
21/03/2023
Summary of Product Characteristics
Français
21/03/2023
Summary of Product Characteristics
Italien
21/03/2023
Patient information leaflet
Allemand
17/03/2023
Patient information leaflet
Français
17/03/2023
Patient information leaflet
Italien
17/03/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
100.0 UG Substance HBESI

Reimbursement information

Public price
CHF 27.25
Specialties list
Yes
Generic
No
SL addition date: 01/07/2000

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
55236
Drug name
Azopt, Augentropfensuspension
Galenic form
AUGN
ATC Code
S01EC04
Authorization status
Z
Dispensing category
B
First authorization
17/12/1999
Authorization expiration date
31/12/9999
IT Number
11.09.0.
Domain
Human medicine
Field of application
Glaukom, okuläre Hypertension

Package details

Description (FR)
AZOPT susp opht fl 5 ml
Description (DE)
AZOPT Susp Opht Fl 5 ml
Market launch
17/12/1999
Narcotic (BTM)
No

Other package sizes (1)

AZOPT susp opht 3 fl 5 ml
3 x 5 ML
GTIN: 7680552360031
View